Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

AQX-016A

😃Good
Catalog No. T8996Cas No. 849669-54-1

AQX-016A is an orally active and potent SHIP1 agonist. It is a structural analog of pelorol and is three times more potent than the marine natural product pelorol at the same molar concentration. AQX-016A can activate recombinant SHIP1 enzyme in vitro and stimulate SHIP1 activity. It also inhibits the PI3K pathway and TNFa production, making it useful for various inflammatory diseases research [1] [2].

AQX-016A

AQX-016A

😃Good
Catalog No. T8996Cas No. 849669-54-1
AQX-016A is an orally active and potent SHIP1 agonist. It is a structural analog of pelorol and is three times more potent than the marine natural product pelorol at the same molar concentration. AQX-016A can activate recombinant SHIP1 enzyme in vitro and stimulate SHIP1 activity. It also inhibits the PI3K pathway and TNFa production, making it useful for various inflammatory diseases research [1] [2].
Pack SizePriceAvailabilityQuantity
25 mg$2,1406-8 weeks
50 mg$2,7856-8 weeks
100 mg$3,5206-8 weeks
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
AQX-016A is an orally active and potent SHIP1 agonist. It is a structural analog of pelorol and is three times more potent than the marine natural product pelorol at the same molar concentration. AQX-016A can activate recombinant SHIP1 enzyme in vitro and stimulate SHIP1 activity. It also inhibits the PI3K pathway and TNFa production, making it useful for various inflammatory diseases research [1] [2].
In vitro
AQX-016A, across various concentrations and durations (0-15 μM, 0-90 min), demonstrably modulates immune response and signaling pathways through specific inhibition and activation mechanisms. At 5 μg/mL for 30 minutes, it suppresses the PI3K-mediated rise in intracellular PIP3 by activating a 5' phosphatase enzyme, leading to decreased PIP3 levels [1]. Furthermore, it effectively blocks LPS-induced PKB phosphorylation in a SHIP-dependent manner and significantly curtails TNFα production in J774 and peritoneal macrophages, as well as in BMDM, particularly requiring SHIP for maximum reduction of TNFα and selectively targeting TNF production from SHIP1 +/+ macrophages over SHIP1 -/- ones [1]. Additionally, AQX-016A inhibits TNFα translation and, at increased concentrations, enhances SHIP1 enzyme activity, both in vitro and in intact cells, consequently inhibiting activation of macrophages and mast cells [2]. In a dose-dependent manner, it preferentially prevents LPS-stimulated PKB phosphorylation and inhibits the phosphorylation of PKB, p38 MAPK, and ERK in SHIP1 +/+ mast cells, showcasing its specificity for SHIP-expressing hematopoietic cells, and highlights its potential in targeting PI3K-dependent responses in immune cells in a SHIP-dependent manner [2].
In vivo
AQX-016A, administered orally at a dose of 20 mg/kg once, significantly lowers plasma TNFa levels and reduces inflammation in a mouse model of endotoxemia [1] [2].
Chemical Properties
Molecular Weight328.49
FormulaC22H32O2
Cas No.849669-54-1
Relative Density.1.082 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy AQX-016A | purchase AQX-016A | AQX-016A cost | order AQX-016A | AQX-016A chemical structure | AQX-016A in vivo | AQX-016A in vitro | AQX-016A formula | AQX-016A molecular weight